ENDEAVOR

Striving to improve the quality of life of Barrett’s Esophagus patients.

Find out more about our research
For Patients
For Researchers
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more
ki_logo_rgb-custom20221016133022
st-james-social-share-default
ZAS
UZA_logo
UZ Gent
Universal Dx
Uni Leipzig
UA
Trinity_Main_Logo
Region H
Radboud_university_medical_center_logo
logo-sanraffaele
Leipzig klinik
karolinska-university-hospital-english-logo
HHU
chu-lille
azdelta_logo_cmyk
Amsterdam UMC

Funded by the European Union

The Endeavor research project has received funding from the European Union’s Horizon EU research and innovation programme under grant agreement number: 101136935*.

* Disclaimer: “Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.”

Depositphotos_685111902_S-784
cluster pr

Collaboration with theEU Cluster research projects

ENDEAVOR is part of the Cluster Pragmatic Clinical Trials on Minimally invasive Diagnostics, funded by the European Uninion. Watch the Cluster Video to learn more about each project and the collaboration.

Watch the Cluster Video

Endeavor EU Follow

ENDEAVOR is an EU-funded research project aiming to improve the quality of life and care of patients with Barrett's Esophagus in Europe #EUfunded #HorizonEU

EndeavorEU
Retweet on Twitter Endeavor EU Retweeted
horizoneu Horizon Europe 🇪🇺 @horizoneu ·
30 Mar

How can digital innovation change the way Europe understands and treats cancer?

Join the EU Cancer Mission Conference in Nicosia on 27 April 2026 to explore data-driven projects and strategies to reduce inequalities in cancer care.

🔗http://link.europa.eu/VPbrJh

#MissionCancer

Reply on Twitter 2038630379502850550 Retweet on Twitter 2038630379502850550 7 Like on Twitter 2038630379502850550 11 Twitter 2038630379502850550
endeavoreu Endeavor EU @endeavoreu ·
18 Mar

💥The second blog post of #ENDEAVOR PhD candidate Jennifer Kluczny is live!

👀 Want to find out more about her her day-to-day work? You can read the blog on the website: http://www.endeavoreu.com/blog/ or join her presentation at this week's #ESDE conference in Cologne📢

#EUfunded

Reply on Twitter 2034180567378325506 Retweet on Twitter 2034180567378325506 Like on Twitter 2034180567378325506 Twitter 2034180567378325506
endeavoreu Endeavor EU @endeavoreu ·
12 Mar

💥 Happy to announce that the ENDEAVOR RCT, expected to start in Q2/Q3 2026 following the prospective pilot study, is now available on http://clinicaltrials.gov.

Check out the link to find out more: https://lnkd.in/enV_-HdJ

👀 Any questions? Let us know!

#EUfunded #RCT #NCTnumber

Reply on Twitter 2031992336167665797 Retweet on Twitter 2031992336167665797 Like on Twitter 2031992336167665797 Twitter 2031992336167665797
endeavoreu Endeavor EU @endeavoreu ·
5 Mar

💥 In his first blog post, ENDEAVOR PhD candidate Piotr Twardowski, from @amsterdamumc, explains more about his research focused on health-economic modeling of surveillance strategies.

Interested? Read more on http://endeavoreu.com/blog/ #EUfunded #ClinicalResearch

Reply on Twitter 2029455621192286694 Retweet on Twitter 2029455621192286694 Like on Twitter 2029455621192286694 Twitter 2029455621192286694
Load More